Roche, a leading healthcare company, has unveiled its FDA-approved human papillomavirus (HPV) self-collection solution, marking a significant advancement in cervical cancer screening in the United States. This innovative solution aims to facilitate early detection and intervention for women at risk of developing cervical cancer, providing accessible and reliable screening options. Accessible Screening Option The HPV … Read more